Evaluations of Molecular Diagnostic Biomarkers


Assessment of Molecular Diagnostic Biomarkers A biomarker is a trademark that is even-handedly evaluated and surveyed as a pointer of common biologic methodology, pathogenic techniques, or pharmacologic responses to an accommodating mediation. It used to perceive or avow the proximity of an infirmity or condition of premium or to recognize individuals with a subtype of the ailment.



 


  • PCR enzyme-linked immunosorbent assay
  • Antibodies or proteins
  • Microbial assays
  • Analytical and clinical evaluations
  • Screening

Related Conference of Evaluations of Molecular Diagnostic Biomarkers

January 27-28, 2025

25th World Congress on Medicinal Chemistry and Drug Design

Bangkok, Thailand
March 13-14, 2025

2nd International Conference on Drug Discovery and Development

Prague, Czech Republic
April 07-08, 2025

15th World Congress on Chemistry

Vancouver, Canada
May 14-15, 2025

17th International Conference on Clinical Chemistry

Toronto, Canada
June 25-26, 2025

15th World Congress on Analytical & Bioanalytical Techniques

Aix-en-Provence, France
June 26-27, 2025

14th World Congress on Chromatography

Paris, France
August 18-19, 2025

14th World Congress on Biopolymers and Biomaterials

Valencia, Spain
September 22-23, 2025

21st European Organic Chemistry Congress

Dubai, UAE
October 27-28, 2025

15th International Chemistry Congress

London, UK
November 06-07, 2025

6th World Expo on Biopolymers and Bioplastics

Dubai, UAE
December 08-09, 2025

5th International Conference on Analytical Chemistry

Rome, Italy

Evaluations of Molecular Diagnostic Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in